# A Study of the Hedgehog Pathway Inhibitor GDC-0449 in Healthy Female Subjects of Non-Childbearing Potential

> **NCT00991718** · PHASE1 · COMPLETED · sponsor: **Genentech, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** GDC-0449 oral capsules (non-labeled)
- **DRUG:** GDC-0449 IV injection (labeled)
- **DRUG:** CDC-0449 oral suspension (labeled)

## Key facts

- **NCT ID:** NCT00991718
- **Lead sponsor:** Genentech, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2017-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00991718

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00991718, "A Study of the Hedgehog Pathway Inhibitor GDC-0449 in Healthy Female Subjects of Non-Childbearing Potential". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00991718. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*